Depression warnings for Chantix and Zyban
July 7, 2009Research and Development, Sales and Marketing Chantix, FDA, US, drug safety
Pfizer and GSK's smoking cessations drugs will have to carry strong warnings of depression and other mental health adverse events …
PM Soc’s Digital Media Awards to highlight pioneering work
July 7, 2009Sales and Marketing digi, pm society
UK pharma companies and agencies are being invited to submit entries to the industry's first-ever digital media awards, which aim …
Vasella: on leadership
July 7, 2009Sales and Marketing Novartis, Vasella, leadership, management
Novartis’ chief executive and chairman talks to McKinsey about his personal approach to management and leadership, and examines subjects including …
Pharmaceutical manufacturing: news in brief
July 6, 2009Manufacturing and Production Genzyme, Quotient
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Caraco, MSD, Rottapharm and Almac Pharma Services, …
NHS expectations ‘artificially inflated’
July 6, 2009NHS, healthcare
Expectations of what the NHS can deliver may be artificially inflated by the government's latest grand plan, according to the …
Novasep buys Henogen to get ‘bigger in bio’
July 6, 2009Manufacturing and Production Novasep
French contract manufacturing firm Novasep has acquired a Belgian company, Henogen, in order to expand the range of biologic drugs …
Roche’s ABPI exit – a deliberate snub?
July 3, 2009Research and Development, Sales and Marketing ABPI, Roche
By Nicola O’BrienRoche is yet to explain its controversial exit from the ABPI, but the company seems determined to make …
Euro RSCG buys Medicom
July 3, 2009Medical Communications Euro RSCG, advertising
Euro RSCG Life, one of healthcare's largest communications groups, has acquired the London-based Medicom Group. The medical communications agency is …
HRA Pharma opens UK subsidiary
July 3, 2009Sales and Marketing HRA Pharma
Privately-owned French drug maker HRA Pharma, which specialises in reproductive health and endocrinology, has opened its first UK subsidiary. The …
Asia Pacific vaccines market requires flexible, targeted portfolios
July 2, 2009Research and Development, Sales and Marketing Asia, vaccines
Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific …
Onglyza and Cimzia recommended by CHMP
July 2, 2009Research and Development, Sales and Marketing AZ, BMS, EMEA, Europe, Ongylza
Bristol-Myers Squibb andAstraZeneca's type II diabetes treatment Onglyza is among the brands to have received positive opinions from the Committee …
Pfizer halts Sutent colon cancer trial
July 2, 2009Research and Development, Sales and Marketing Cancer, Pfizer, Sutent
Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …
Coaching your team through testing times
July 2, 2009Business Services coaching, recruitment
A fundamental aim of coaching is to raise our self-awareness, reconnect us with our choices at work and build self-confidence. …
Lonza spat with Altus over manufacturing deal escalates
July 1, 2009Manufacturing and Production Lonza
Altus Therapeutics has officially called a halt to a supply agreement with contract manufacturer Lonza in the latest round of …
Roche quits ABPI
June 30, 2009Research and Development, Sales and Marketing ABPI, Roche, UK
Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …
Is the law good for your health?
June 30, 2009Research and Development Les Rose, law, science
A lawyer once told me that the law has nothing to do with morals. This wasn’t really a surprise, but …
Bayer signs deal with Celera on cancer targets
June 30, 2009Research and Development, Sales and Marketing Bayer, Celera
Bayer Schering Pharma has signed a deal with Celera to give it access to five cancer-related targets for therapeutic development …
Satchell to lead Rock Medical Communications
June 30, 2009Medical Communications Creston, Med Comms, Rock Medical
Rock Medical Communications has been launched as part of the Creston Health group. The company will deliver medical education programmes, …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
